- Home
- XYF vs DERM Comparison
XYF vs DERM Comparison
Compare XYF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | DERM |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.3M | 257.1M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XYF | DERM |
|---|---|---|
| Price | $5.00 | $8.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | ★ 189.0K | 82.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.16% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,134,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.78 | $4.97 |
| 52 Week High | $20.36 | $9.56 |
Technical Indicators
Market Signals| Indicator | XYF | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 38.22 | 51.55 |
| Support Level | $4.93 | $6.71 |
| Resistance Level | $5.52 | $8.71 |
| Average True Range (ATR) | 0.21 | 0.48 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 28.57 | 57.68 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.